Abstract:Antibiotic resistance of bacteria has been widely developed due to biofilm protection and separating the bacteria from antibiotics. The phenomenon of biofilm inhibition or disassembly by d-amino acids (DAAs) has been reported recently, while it was also challenged by some other scientists. Presuming DAAs work for biofilms on the surface of bacteria, delivery of the DAAs to disease sites is important while small DAAs are easily removed by kidney. To resolve the above issues, it is urgent to develop a biofilm inhibitor. To achieve this goal, we synthesized d-type polypeptides via NCA ring-opening polymerization with the initiator of HMDS to generate poly(CBZ-l-lysine)33-block-poly(d-phenylalanine)14. After deprotection, the resultant polypeptides were converted into amphiphilic poly(l-lysine)33-block-poly(d-phenylalanine)14, which can be self-assembled into well-defined homogeneous nanoparticles capable of capsulizing penicillin G. For the molecular weight of polypeptides resulting in various bioeffects, we prepared similar-sized polypeptides of an l-type equivalent polypeptide as control. The data from microbial experiments indicated that poly(l-lysine)33-block-poly(d-phenylalanine)14 can inhibit biofilm formation of Bacillus subtilis at a low final concentration (24 μg/mL), much stronger than poly(l-lysine)40-block-poly(l-phenylalanine)19 at the same concentration. This is the first report in that synthetic d-type polypeptides can inhibit biofilms of bacteria. Poly(l-lysine)33-block-poly(d-phenylalanine)14 can be assembled into well-defined, biostable homogeneous nanoparticles. This research provides a potential solution to overcome bacteria antibiotic resistance from small molecules to material sciences and gives a unique angle to understand the current dispute if DAAs can disassemble the biofilms. Additionally, these nanoparticles have great potential in the development of nanomedicines with a longer circulation time in blood and this discovery has implications in developing antimicrobial nanodevices for therapy and basic scientific interest.

Lysine and citric acid based pegylated polymeric dendritic nano drug delivery carrier and their bioactivity evaluation

Synthesis, characterization and evaluation of pegylated-citric acid based dendrimers as drug delivery agents

Dendritic phospholipid-based drug delivery systems

Synthesis of Degradable Bifunctional Dendritic Polymers As Versatile Drug Carriers

Lauryl alcohol functionalized citric acid-based dendrimers as the drug carrier for in vitro evaluation

Bactericidal Dendritic Polycation Cloaked with Stealth Material Via Lipase-Sensitive Intersegment Acquires Neutral Surface Charge Without Losing Membrane-Disruptive Activity

Dendrimer, Liposomes, Carbon Nanotubes and PLGA Nanoparticles: One Platform Assessment of Drug Delivery Potential

Non-ionic PEG-oligoglycerol dendron conjugated nano-carriers for dermal drug delivery

Peptide-Based Multicomponent Oligonucleotide Delivery Systems: Optimisation of Poly-l-lysine Dendrons for Plasmid DNA Delivery

Synthesis of PEGylated PAMAM Dendrimer As a Drug Carrier

Targeting the phosphatidylglycerol lipid: An amphiphilic dendrimer as a promising antibacterial candidate

Evaluation of drug release efficiency and antibacterial property of a pH-responsive dextran-based silver nanocomposite hydrogel

New cyclodextrin derivative containing poly(L-lysine) dendrons for gene and drug co-delivery.

POLY(L-GLUTAMIC ACID)DENDRON BASED Ph SENSITIVE DRUG CARRIER WITH MAGNETIC NANOPARTICLE CORE

Quantitative assessment of surface functionality effects on microglial uptake and retention of PAMAM dendrimers

PEGylated PAMAM Dendrimers As a Potential Drug Delivery Carrier:In Vitroandin Vivocomparative Evaluation of Covalently Conjugated Drug and Noncovalent Drug Inclusion Complex

N-Lipidated Peptide Dimers: Effective Antibacterial Agents Against Gram-Negative Pathogens Through Lipopolysaccharide Permeabilization

Controlled Block Polypeptide Composed of D-Type Amino Acids: A Therapeutics Delivery Platform to Inhibit Biofilm Formation of Drug-Resistant Bacteria

Synthesis of N-acetylcysteine functionalized cholic acid based triarmed poly DL-Lactide and encapsulation of gold nanoparticles: Studies on the antimicrobial activity and biocompatibility for drug delivery applications

Pyramid-Shaped PEG-PCL-PEG Polymeric-Based Model Systems for Site-Specific Drug Delivery of Vancomycin with Enhance Antibacterial Efficacy

Conjugation of Gentamicin to Polyamidoamine Dendrimers Improved Anti-bacterial Properties against Pseudomonas aeruginosa